Abstract:The circadian machinery is critical for the normal physiological functions and cellular processes. Circadian rhythm disruption has been associated with immune suppression which leads to higher cancer risk, suggesting a putative tumor protective role of circadian clock homeostasis. CBX4, as an epigenetic regulator, has been explored for its involvement in tumorigenesis. However, little is known about the correlation between CBX4 and circadian rhythm disruption in colon cancer as well as the potential impact on the tumor immunity. A significant upregulation of CBX4 was identified in the TCGA colon adenocarcinoma (COAD) samples when compared with the normal controls ( p < 0.001). This differential expression was confirmed at the protein level using colon adenocarcinoma tissue array ( p < 0.01). CBX4 was up-regulated in the recurred/progressed colon cancer cases compared with the disease-free samples (p < 0.01), suggesting CBX4 as a potential predictor for poor prognosis. With regard to nodular metastasis, CBX4 was found to be associated with early onset of metastatic diseases but not late progression. The circadian rhythm is orchestrated by the alternating activation and suppression of the CLOCK/ARNTL-driven positive loop and the PER/CRY-controlled negative loop. In COAD, CBX4 was negatively correlated with CLOCK ( p < 0.001), and positively correlated with PER1 ( p < 0.001), PER3 ( p < 0.01), and CRY2 ( p < 0.001) as well as NR1D1 ( p < 0.001), a critical negative regulator of the circadian clock. These interactions consistently impacted on patient survival based on the colorectal cancer cohorts GSE17536 and GSE14333 of PrognoScan. CBX4 showed significant negative correlations with infiltrating B cells ( p < 0.05) and CD4 + T cells ( p < 0.01), and positive correlations with myeloid derived suppressor cells (MDSCs) ( p < 0.05) and cancer associated fibroblast (CAFs) ( p < 0.001), as well as a low immunoscore. Moreover, CBX4 displayed significant correlations with diverse immune metagenes. PER1 and PER3, consistent with their coordinated expression with CBX4, also had strong correlations with these gene representatives in COAD, suggesting a potential interaction of CBX4 with the circadian machinery. Our studies implicate that CBX4 may contribute to colon cancer development via potential influence on circadian rhythm and immune infiltration. These findings provide new insights into deciphering the function of CBX4, and may contribute to the development of new targeting strategies.

CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.

CBX3 promotes breast cancer progression and high level of CBX3 predicts poor prognosis in patients

CBX3 Promotes Tumor Proliferation by Regulating G1/S Phase Via P21 Downregulation and Associates with Poor Prognosis in Tongue Squamous Cell Carcinoma.

The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53

Clinical Significance of Expression of CBX3 in Colorectal Cancer and its Possible Mechanism

CBX4 Suppresses Metastasis Via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma.

CBX3 Promotes Proliferation and Regulates Glycolysis Via Suppressing FBP1 in Pancreatic Cancer.

CXCL3 contributes to CD133 + CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation

CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity

CBX7 Regulates Stem Cell-Like Properties of Gastric Cancer Cells Via P16 and AKT-NF-κB-miR-21 Pathways.

Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression

Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses

CDCA3 Mediates P21-Dependent Proliferation by Regulating E2F1 Expression in Colorectal Cancer

PBX3 is Associated with Proliferation and Poor Prognosis in Patients with Cervical Cancer.

Paradoxical Role of Cbx8 in Proliferation and Metastasis of Colorectal Cancer

CBX4 Provides an Alternate Mode of Colon Cancer Development <i>via</i> Potential Influences on Circadian Rhythm and Immune Infiltration

CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway

CBX4 Provides an Alternate Mode of Colon Cancer Development via Potential Influences on Circadian Rhythm and Immune Infiltration

Integrative Analysis of Genetic and Epigenetic Alterations in the CBX7 Gene Reveals Its Tumor-Suppressive Function by Regulating the Cell Cycle in Human Breast Cancer

Clinicopathological significance of CBX3 in colorectal cancer: An intensive expression study based on formalin-fixed and paraffin-embedded tissues

CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression